Women's Health

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alert
nasal spray
FDA Alert
FDA Approves First Self-Administered Nasal Spray Influenza Vaccine
09/27/2024
Anthony Calabro, MA
The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.
09/27/2024
FDA ALERT
chemo
FDA ALERT
FDA Approves Pembrolizumab With Chemotherapy to Treat Primary Advance or Recurrent Endometrial Carcinoma in Patients
09/13/2024
Jessica Ganga
In June, following a placebo-controlled trial, the FDA approved pembrolizumab with chemotherapy to treat patients with primary advanced or recurrent endometrial carcinoma.
09/13/2024
FDA Alert
shutterstock
FDA Alert
FDA Approves First Dissolvable Birth Control Pill
07/31/2024
Anthony Calabro, MA
The first orally disintegrating birth control tablet was designed for individuals who have trouble swallowing their medication.
07/31/2024
FDA Alert
Fda alert
FDA Alert
FDA Approves First Oral Medication for Treatment of Postpartum Depression
10/04/2023
Jessica Ganga
Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.
10/04/2023
FDA Alert
fda
FDA Alert
FDA Approves First RSV Vaccine For Pregnant Individuals
08/24/2023
Anthony Calabro, MA
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
08/24/2023
FDA Alert
pills
FDA Alert
FDA Approves First Over-The-Counter, Nonprescription Daily Oral Contraceptive
07/21/2023
Jessica Ganga
The FDA has approved the first daily oral contraceptive for the prevention of pregnancy that does not require a health care provider’s prescription.
07/21/2023
fda alert
fda
fda alert
FDA Approves Novel Treatment for Menopausal Hot Flashes
06/07/2023
Leigh Precopio
The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.
06/07/2023
Women's Health
Women's Health
FDA Approves New Diagnostic Drug for Identifying Ovarian Cancer Tissue
12/02/2021
The drug is approved as a diagnostic tool to help identify cancerous lesions during surgery, which is normally difficult to detect. The drug is administered intravenously prior to surgery.
12/02/2021
Gynecology
Gynecology
FDA Approves New Option for Heavy Menstrual Bleeding
06/01/2020
The FDA has approved a new option for the treatment of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.
06/01/2020
Sexual Dysfunction
Sexual Dysfunction
FDA Approves First Drug for Hypoactive Sexual Desire Disorder in Women
08/19/2015
The FDA has approved the first drug for the treatment of generalized hypoactive sexual desire disorder in premenopausal women.
08/19/2015